PARP1 and coronary artery disorder: In the coronary heart disease (CHD) model, 80 mg/kg dioscin also antagonized apoptosis, inflammation and oxidative stress by promoting Sirt1/Nrf2 and inhibiting p38 MAPK and PARP/p53 expression [168].